Haemonetics (HAE) vs MiniMed Group (MMED)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
MiniMed Group is the larger company by market cap ($5.57 billion vs $5.44 billion), about 1.0 times the size. On valuation, Haemonetics trades at a lower forward P/E (20.5x vs 31.1x for MiniMed Group). Haemonetics converts more of its revenue into profit, with a net margin of 7.3% versus -10.7%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HAE | MMED |
|---|---|---|
| Share price | $119.47 | $19.80 |
| Market cap | $5.44B | $5.57B |
| 1-day change | +17.46% | +3.61% |
| YTD return | +49.06% | — |
| 1-year return | +134.35% | — |
| 5-year return | +70.89% | — |
| P/E ratio (TTM) | 57.71 | — |
| Forward P/E | 20.53 | 31.07 |
| EPS (TTM) | $2.07 | $-1.53 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $1.33B | $3.10B |
| Revenue growth (YoY) | -1.97% | +14.25% |
| Net income (latest FY) | $97.31M | $-333.00M |
| Gross margin | 59.04% | 54.16% |
| Operating margin | 11.75% | -6.13% |
| Net margin | 7.29% | -10.74% |
| 52-week high | $121.00 | $24.43 |
| 52-week low | $48.17 | $10.65 |
| Distance from 52-week high | -1.26% | -18.95% |
| Analyst consensus | buy | buy |
| Avg. price target upside | -6.67% | +24.70% |
| Average volume | 715.68K | 2.48M |
| Shares outstanding | 45.50M | 281.35M |
| Employees | 3,009 | 8,000 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Haemonetics is more profitable, keeping 7.3 cents of every revenue dollar as net income versus -10.7 cents for MiniMed Group.
- MiniMed Group grew revenue faster in its latest fiscal year (+14.25% vs -1.97%).
About Haemonetics
HAE stock →Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions. The company operates through Plasma, Blood Center, and Hospital segments.
Health Care · Medical/Dental Instruments · 3,009 employees
About MiniMed Group
MMED stock →MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes.
Health Care · Medical/Dental Instruments · 8,000 employees
HAE vs MMED FAQ
Which is bigger, Haemonetics or MiniMed Group?
MiniMed Group (MMED) is larger, with a market capitalization of $5.57B compared with $5.44B for Haemonetics (HAE).
Are Haemonetics and MiniMed Group in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.